Magnesium in PDB 4qwg: Ycp BETA5-A49V Mutant in Complex with Carfilzomib
Protein crystallography data
The structure of Ycp BETA5-A49V Mutant in Complex with Carfilzomib, PDB code: 4qwg
was solved by
E.M.Huber,
W.Heinemeyer,
M.Groll,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
15.00 /
2.60
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
136.980,
301.070,
145.940,
90.00,
112.89,
90.00
|
R / Rfree (%)
|
21.6 /
24.3
|
Other elements in 4qwg:
The structure of Ycp BETA5-A49V Mutant in Complex with Carfilzomib also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Ycp BETA5-A49V Mutant in Complex with Carfilzomib
(pdb code 4qwg). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 6 binding sites of Magnesium where determined in the
Ycp BETA5-A49V Mutant in Complex with Carfilzomib, PDB code: 4qwg:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
6;
Magnesium binding site 1 out
of 6 in 4qwg
Go back to
Magnesium Binding Sites List in 4qwg
Magnesium binding site 1 out
of 6 in the Ycp BETA5-A49V Mutant in Complex with Carfilzomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Ycp BETA5-A49V Mutant in Complex with Carfilzomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
G:Mg301
b:48.5
occ:1.00
|
O
|
G:ARG122
|
2.3
|
49.3
|
1.0
|
O
|
G:MET125
|
2.3
|
50.2
|
1.0
|
OG1
|
G:THR8
|
2.6
|
39.9
|
1.0
|
O
|
G:TYR119
|
2.7
|
37.7
|
1.0
|
O
|
G:ALA123
|
3.2
|
55.3
|
1.0
|
CG2
|
G:THR8
|
3.4
|
41.8
|
1.0
|
C
|
G:ARG122
|
3.4
|
47.5
|
1.0
|
C
|
G:MET125
|
3.5
|
47.3
|
1.0
|
C
|
G:ALA123
|
3.6
|
50.2
|
1.0
|
CA
|
G:ALA123
|
3.6
|
47.0
|
1.0
|
CB
|
G:THR8
|
3.6
|
41.8
|
1.0
|
C
|
G:TYR119
|
3.9
|
38.8
|
1.0
|
N
|
G:ALA123
|
3.9
|
44.2
|
1.0
|
N
|
G:MET125
|
4.2
|
50.2
|
1.0
|
N
|
G:THR8
|
4.4
|
44.4
|
1.0
|
N
|
G:ARG126
|
4.4
|
41.3
|
1.0
|
CA
|
G:ARG126
|
4.4
|
40.2
|
1.0
|
CA
|
G:MET125
|
4.4
|
50.6
|
1.0
|
N
|
G:TYR124
|
4.5
|
51.1
|
1.0
|
CA
|
G:THR8
|
4.6
|
44.1
|
1.0
|
CA
|
G:TYR119
|
4.6
|
37.7
|
1.0
|
CA
|
G:ARG122
|
4.7
|
49.6
|
1.0
|
CD
|
G:PRO127
|
4.7
|
38.5
|
1.0
|
N
|
G:ARG122
|
4.8
|
46.3
|
1.0
|
CB
|
G:ALA123
|
4.9
|
46.5
|
1.0
|
N
|
G:THR120
|
4.9
|
39.6
|
1.0
|
C
|
G:ARG126
|
5.0
|
39.6
|
1.0
|
CB
|
G:MET125
|
5.0
|
56.9
|
1.0
|
|
Magnesium binding site 2 out
of 6 in 4qwg
Go back to
Magnesium Binding Sites List in 4qwg
Magnesium binding site 2 out
of 6 in the Ycp BETA5-A49V Mutant in Complex with Carfilzomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Ycp BETA5-A49V Mutant in Complex with Carfilzomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
I:Mg301
b:60.8
occ:1.00
|
O
|
I:ASP177
|
2.5
|
37.9
|
1.0
|
O
|
I:SER180
|
2.7
|
43.2
|
1.0
|
O
|
I:ALA174
|
3.1
|
44.6
|
1.0
|
OXT
|
I:ASP204
|
3.6
|
50.6
|
1.0
|
C
|
I:ASP177
|
3.6
|
38.3
|
1.0
|
C
|
I:SER180
|
4.0
|
39.7
|
1.0
|
O
|
I:HOH409
|
4.0
|
40.2
|
1.0
|
O
|
I:ALA178
|
4.1
|
37.5
|
1.0
|
CA
|
I:ALA178
|
4.2
|
37.2
|
1.0
|
C
|
I:ALA174
|
4.2
|
44.0
|
1.0
|
C
|
I:ALA178
|
4.3
|
37.6
|
1.0
|
N
|
I:ALA178
|
4.4
|
37.2
|
1.0
|
CA
|
I:ASP175
|
4.4
|
44.1
|
1.0
|
O
|
I:ASP204
|
4.4
|
53.2
|
1.0
|
C
|
I:ASP204
|
4.5
|
52.7
|
1.0
|
NH1
|
Y:ARG19
|
4.5
|
49.5
|
1.0
|
C
|
I:ASP175
|
4.6
|
43.3
|
1.0
|
O
|
I:ASP175
|
4.6
|
44.7
|
1.0
|
N
|
I:ASP177
|
4.6
|
37.8
|
1.0
|
N
|
I:SER180
|
4.7
|
36.8
|
1.0
|
CA
|
I:ASP177
|
4.7
|
39.3
|
1.0
|
N
|
I:ASP175
|
4.8
|
43.1
|
1.0
|
CA
|
I:GLY181
|
4.8
|
40.5
|
1.0
|
NH2
|
Y:ARG19
|
4.8
|
48.8
|
1.0
|
N
|
I:GLY181
|
4.8
|
40.2
|
1.0
|
CA
|
I:SER180
|
4.9
|
38.8
|
1.0
|
|
Magnesium binding site 3 out
of 6 in 4qwg
Go back to
Magnesium Binding Sites List in 4qwg
Magnesium binding site 3 out
of 6 in the Ycp BETA5-A49V Mutant in Complex with Carfilzomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Ycp BETA5-A49V Mutant in Complex with Carfilzomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
K:Mg302
b:48.6
occ:1.00
|
O
|
K:ASP168
|
2.1
|
37.7
|
1.0
|
O
|
K:ALA165
|
2.2
|
39.6
|
1.0
|
O
|
W:ASP204
|
2.4
|
46.9
|
1.0
|
O
|
K:SER171
|
2.6
|
39.4
|
1.0
|
C
|
W:ASP204
|
3.2
|
48.1
|
1.0
|
C
|
K:ASP168
|
3.2
|
37.3
|
1.0
|
C
|
K:ALA165
|
3.3
|
39.2
|
1.0
|
CA
|
W:ASP204
|
3.6
|
47.0
|
1.0
|
C
|
K:SER171
|
3.8
|
38.0
|
1.0
|
CA
|
K:ALA169
|
3.8
|
37.3
|
1.0
|
CB
|
W:ASP204
|
3.9
|
47.3
|
1.0
|
N
|
K:ALA169
|
3.9
|
36.7
|
1.0
|
O
|
K:HIS166
|
3.9
|
40.0
|
1.0
|
C
|
K:ALA169
|
4.0
|
37.9
|
1.0
|
O
|
K:ALA169
|
4.1
|
37.5
|
1.0
|
OXT
|
W:ASP204
|
4.1
|
49.1
|
1.0
|
C
|
K:HIS166
|
4.2
|
39.0
|
1.0
|
CA
|
K:ALA165
|
4.2
|
39.0
|
1.0
|
NH1
|
K:ARG19
|
4.2
|
44.2
|
1.0
|
N
|
K:ASP168
|
4.3
|
38.6
|
1.0
|
N
|
K:SER171
|
4.3
|
37.0
|
1.0
|
N
|
K:HIS166
|
4.3
|
38.6
|
1.0
|
CA
|
K:ASP168
|
4.3
|
38.2
|
1.0
|
O
|
K:ALA164
|
4.4
|
38.0
|
1.0
|
CA
|
K:HIS166
|
4.4
|
38.7
|
1.0
|
CA
|
K:SER171
|
4.5
|
36.6
|
1.0
|
C
|
K:ARG167
|
4.7
|
38.9
|
1.0
|
CZ
|
K:ARG19
|
4.7
|
43.1
|
1.0
|
N
|
K:ARG167
|
4.7
|
39.7
|
1.0
|
N
|
K:GLY172
|
4.8
|
39.4
|
1.0
|
N
|
K:TYR170
|
4.8
|
38.2
|
1.0
|
CA
|
K:GLY172
|
4.9
|
39.9
|
1.0
|
CB
|
K:SER171
|
4.9
|
34.9
|
1.0
|
NH2
|
K:ARG19
|
4.9
|
46.9
|
1.0
|
CG
|
W:ASP204
|
5.0
|
48.1
|
1.0
|
N
|
W:ASP204
|
5.0
|
46.1
|
1.0
|
|
Magnesium binding site 4 out
of 6 in 4qwg
Go back to
Magnesium Binding Sites List in 4qwg
Magnesium binding site 4 out
of 6 in the Ycp BETA5-A49V Mutant in Complex with Carfilzomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Ycp BETA5-A49V Mutant in Complex with Carfilzomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
N:Mg202
b:49.0
occ:1.00
|
O
|
N:ILE163
|
2.6
|
37.7
|
1.0
|
O
|
N:SER169
|
2.6
|
40.9
|
1.0
|
O
|
N:ASP166
|
2.9
|
43.4
|
1.0
|
CD1
|
a:LEU34
|
3.7
|
47.8
|
1.0
|
C
|
N:ILE163
|
3.7
|
43.3
|
1.0
|
C
|
N:SER169
|
3.8
|
40.1
|
1.0
|
NH1
|
N:ARG19
|
3.8
|
46.4
|
1.0
|
CG2
|
N:ILE163
|
3.9
|
45.3
|
1.0
|
C
|
N:ASP166
|
4.0
|
42.3
|
1.0
|
CA
|
N:GLY167
|
4.3
|
40.7
|
1.0
|
CA
|
N:ILE163
|
4.4
|
44.3
|
1.0
|
CA
|
N:GLY170
|
4.5
|
43.0
|
1.0
|
CZ
|
N:ARG19
|
4.5
|
44.4
|
1.0
|
N
|
N:GLY167
|
4.6
|
40.1
|
1.0
|
N
|
N:GLY170
|
4.6
|
42.0
|
1.0
|
O
|
a:HOH322
|
4.6
|
42.3
|
1.0
|
O
|
N:GLY167
|
4.6
|
41.7
|
1.0
|
C
|
N:GLY167
|
4.6
|
39.6
|
1.0
|
N
|
N:LYS164
|
4.7
|
45.1
|
1.0
|
CB
|
N:ILE163
|
4.8
|
44.2
|
1.0
|
N
|
N:SER169
|
4.8
|
39.2
|
1.0
|
NH2
|
N:ARG19
|
4.8
|
44.6
|
1.0
|
CA
|
N:SER169
|
4.8
|
38.9
|
1.0
|
O
|
N:LYS164
|
4.9
|
48.2
|
1.0
|
C
|
N:LYS164
|
4.9
|
47.3
|
1.0
|
CA
|
N:LYS164
|
4.9
|
46.8
|
1.0
|
CG
|
a:LEU34
|
5.0
|
46.9
|
1.0
|
|
Magnesium binding site 5 out
of 6 in 4qwg
Go back to
Magnesium Binding Sites List in 4qwg
Magnesium binding site 5 out
of 6 in the Ycp BETA5-A49V Mutant in Complex with Carfilzomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Ycp BETA5-A49V Mutant in Complex with Carfilzomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
V:Mg302
b:45.5
occ:1.00
|
O
|
V:ASP166
|
2.1
|
43.6
|
1.0
|
OXT
|
L:ASP222
|
2.3
|
58.4
|
1.0
|
O
|
V:SER169
|
2.3
|
41.4
|
1.0
|
O
|
V:ILE163
|
2.3
|
47.4
|
1.0
|
O
|
V:HOH401
|
2.6
|
38.7
|
1.0
|
C
|
V:ASP166
|
3.2
|
43.8
|
1.0
|
C
|
L:ASP222
|
3.3
|
60.7
|
1.0
|
C
|
V:ILE163
|
3.4
|
46.7
|
1.0
|
C
|
V:SER169
|
3.4
|
41.3
|
1.0
|
CA
|
L:ASP222
|
3.8
|
58.3
|
1.0
|
O
|
V:GLY162
|
3.9
|
42.1
|
1.0
|
CA
|
V:LEU167
|
3.9
|
43.1
|
1.0
|
N
|
V:LEU167
|
3.9
|
43.8
|
1.0
|
NH1
|
V:ARG19
|
4.0
|
47.2
|
1.0
|
N
|
V:ASP166
|
4.1
|
43.6
|
1.0
|
CA
|
V:ILE163
|
4.2
|
48.0
|
1.0
|
O
|
L:ASP222
|
4.2
|
63.2
|
1.0
|
CA
|
V:ASP166
|
4.2
|
44.3
|
1.0
|
N
|
V:SER169
|
4.3
|
39.6
|
1.0
|
CB
|
L:ASP222
|
4.3
|
60.1
|
1.0
|
N
|
V:GLY170
|
4.3
|
43.9
|
1.0
|
C
|
V:LEU167
|
4.3
|
42.6
|
1.0
|
N
|
V:TRP164
|
4.3
|
46.4
|
1.0
|
CA
|
V:GLY170
|
4.3
|
44.9
|
1.0
|
C
|
V:TRP164
|
4.3
|
47.9
|
1.0
|
CA
|
V:SER169
|
4.3
|
40.4
|
1.0
|
O
|
V:TRP164
|
4.4
|
48.6
|
1.0
|
CZ
|
V:ARG19
|
4.5
|
46.0
|
1.0
|
CA
|
V:TRP164
|
4.5
|
48.3
|
1.0
|
O
|
V:LEU167
|
4.6
|
41.9
|
1.0
|
N
|
V:ASN165
|
4.7
|
47.6
|
1.0
|
NH2
|
V:ARG19
|
4.7
|
48.0
|
1.0
|
CB
|
V:SER169
|
4.8
|
40.5
|
1.0
|
C
|
V:GLY162
|
4.8
|
45.9
|
1.0
|
C
|
V:ASN165
|
4.8
|
43.1
|
1.0
|
CB
|
V:ASP166
|
4.9
|
43.7
|
1.0
|
N
|
V:GLY168
|
4.9
|
40.8
|
1.0
|
|
Magnesium binding site 6 out
of 6 in 4qwg
Go back to
Magnesium Binding Sites List in 4qwg
Magnesium binding site 6 out
of 6 in the Ycp BETA5-A49V Mutant in Complex with Carfilzomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 6 of Ycp BETA5-A49V Mutant in Complex with Carfilzomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
Y:Mg302
b:42.9
occ:1.00
|
O
|
Y:ASP168
|
2.2
|
38.4
|
1.0
|
O
|
Y:ALA165
|
2.3
|
37.9
|
1.0
|
O
|
Y:SER171
|
2.4
|
40.5
|
1.0
|
O
|
I:ASP204
|
2.5
|
53.2
|
1.0
|
O
|
Y:HOH415
|
2.5
|
41.2
|
1.0
|
C
|
I:ASP204
|
3.2
|
52.7
|
1.0
|
C
|
Y:ASP168
|
3.3
|
37.0
|
1.0
|
C
|
Y:ALA165
|
3.4
|
37.3
|
1.0
|
C
|
Y:SER171
|
3.6
|
38.3
|
1.0
|
CA
|
I:ASP204
|
3.6
|
52.4
|
1.0
|
CA
|
Y:ALA169
|
3.8
|
36.6
|
1.0
|
CB
|
I:ASP204
|
3.9
|
53.0
|
1.0
|
C
|
Y:ALA169
|
4.0
|
36.6
|
1.0
|
N
|
Y:ALA169
|
4.0
|
36.7
|
1.0
|
O
|
Y:ALA169
|
4.0
|
38.3
|
1.0
|
NH1
|
Y:ARG19
|
4.0
|
49.5
|
1.0
|
N
|
Y:SER171
|
4.1
|
35.4
|
1.0
|
O
|
Y:HIS166
|
4.1
|
39.1
|
1.0
|
OXT
|
I:ASP204
|
4.2
|
50.6
|
1.0
|
CA
|
Y:ALA165
|
4.2
|
37.2
|
1.0
|
C
|
Y:HIS166
|
4.3
|
39.9
|
1.0
|
CA
|
Y:SER171
|
4.4
|
35.6
|
1.0
|
N
|
Y:HIS166
|
4.4
|
37.9
|
1.0
|
N
|
Y:ASP168
|
4.4
|
37.4
|
1.0
|
CA
|
Y:ASP168
|
4.4
|
36.1
|
1.0
|
O
|
Y:ALA164
|
4.5
|
33.8
|
1.0
|
CZ
|
Y:ARG19
|
4.5
|
46.4
|
1.0
|
N
|
Y:GLY172
|
4.6
|
39.5
|
1.0
|
CA
|
Y:HIS166
|
4.6
|
38.3
|
1.0
|
N
|
Y:TYR170
|
4.7
|
35.6
|
1.0
|
CA
|
Y:GLY172
|
4.7
|
40.9
|
1.0
|
NH2
|
Y:ARG19
|
4.7
|
48.8
|
1.0
|
CB
|
Y:SER171
|
4.8
|
35.8
|
1.0
|
C
|
Y:ARG167
|
4.9
|
38.0
|
1.0
|
N
|
Y:ARG167
|
4.9
|
40.0
|
1.0
|
CG
|
I:ASP204
|
4.9
|
53.8
|
1.0
|
|
Reference:
E.M.Huber,
W.Heinemeyer,
M.Groll.
Bortezomib-Resistant Mutant Proteasomes: Structural and Biochemical Evaluation with Carfilzomib and Onx 0914. Structure 2015.
ISSN: ISSN 0969-2126
PubMed: 25599643
DOI: 10.1016/J.STR.2014.11.019
Page generated: Tue Aug 20 02:28:33 2024
|